October 30, 2026 at 08:06 PM UTC
Allarity Therapeutics, Inc. reports termination of material agreement
Allarity Therapeutics, Inc. filed an 8-K covering termination of a material definitive agreement. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.
Official source: U.S. Securities and Exchange Commission
Official source published: October 30, 2026 at 08:05 PM UTC
Open official source